Literature DB >> 16611996

Neuroprotection by histone deacetylase-related protein.

Brad E Morrison1, Nazanin Majdzadeh, Xiaoguang Zhang, Aaron Lyles, Rhonda Bassel-Duby, Eric N Olson, Santosh R D'Mello.   

Abstract

The expression of histone deacetylase-related protein (HDRP) is reduced in neurons undergoing apoptosis. Forced reduction of HDRP expression in healthy neurons by treatment with antisense oligonucleotides also induces cell death. Likewise, neurons cultured from mice lacking HDRP are more vulnerable to cell death. Adenovirally mediated expression of HDRP prevents neuronal death, showing that HDRP is a neuroprotective protein. Neuroprotection by forced expression of HDRP is not accompanied by activation of the phosphatidylinositol 3-kinase-Akt or Raf-MEK-ERK signaling pathway, and treatment with pharmacological inhibitors of these pathways fails to inhibit the neuroprotection by HDRP. Stimulation of c-Jun phosphorylation and expression, an essential feature of neuronal death, is prevented by HDRP. We found that HDRP associates with c-Jun N-terminal kinase (JNK) and inhibits its activity, thus explaining the inhibition of c-Jun phosphorylation by HDRP. HDRP also interacts with histone deacetylase 1 (HDAC1) and recruits it to the c-Jun gene promoter, resulting in an inhibition of histone H3 acetylation at the c-Jun promoter. Although HDRP lacks intrinsic deacetylase activity, treatment with pharmacological inhibitors of histone deacetylases induces apoptosis even in the presence of ectopically expressed HDRP, underscoring the importance of c-Jun promoter deacetylation by HDRP-HDAC1 in HDRP-mediated neuroprotection. Our results suggest that neuroprotection by HDRP is mediated by the inhibition of c-Jun through its interaction with JNK and HDAC1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611996      PMCID: PMC1447420          DOI: 10.1128/MCB.26.9.3550-3564.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5.

Authors:  X Zhou; V M Richon; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  Regulating histone acetyltransferases and deacetylases.

Authors:  Gaëlle Legube; Didier Trouche
Journal:  EMBO Rep       Date:  2003-10       Impact factor: 8.807

Review 3.  Targeting the JNK signaling pathway for stroke and Parkinson's diseases therapy.

Authors:  Chia-Yi Kuan; Robert E Burke
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2005-02

4.  Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.

Authors:  J Lu; T A McKinsey; R L Nicol; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

Review 5.  c-Jun and the transcriptional control of neuronal apoptosis.

Authors:  J Ham; A Eilers; J Whitfield; S J Neame; B Shah
Journal:  Biochem Pharmacol       Date:  2000-10-15       Impact factor: 5.858

6.  Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death.

Authors:  Timothy A Bolger; Tso-Pang Yao
Journal:  J Neurosci       Date:  2005-10-12       Impact factor: 6.167

7.  The histone deacetylase 9 gene encodes multiple protein isoforms.

Authors:  Kevin Petrie; Fabien Guidez; Louise Howell; Lyn Healy; Samuel Waxman; Mel Greaves; Arthur Zelent
Journal:  J Biol Chem       Date:  2003-02-17       Impact factor: 5.157

8.  Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+) //calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival.

Authors:  Daniel A Linseman; Christopher M Bartley; Shoshona S Le; Tracey A Laessig; Ron J Bouchard; Mary Kay Meintzer; Mingtao Li; Kim A Heidenreich
Journal:  J Biol Chem       Date:  2003-08-01       Impact factor: 5.157

Review 9.  Targeting the JNK pathway for therapeutic benefit in CNS disease.

Authors:  Donna Bozyczko-Coyne; Michael S Saporito; Robert L Hudkins
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2002-02

10.  Loss of heterozygosity at 7p in Wilms' tumour development.

Authors:  R M Powlesland; A K Charles; K T Malik; P A Reynolds; S Pires; M Boavida; K W Brown
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

View more
  48 in total

1.  Transducin-like enhancer of Split-1 (TLE1) combines with Forkhead box protein G1 (FoxG1) to promote neuronal survival.

Authors:  Somasish Ghosh Dastidar; Sriram Narayanan; Stefano Stifani; Santosh R D'Mello
Journal:  J Biol Chem       Date:  2012-02-21       Impact factor: 5.157

2.  Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells.

Authors:  Shalini A Muralidhar; Valya Ramakrishnan; Inderdeep S Kalra; Wei Li; Betty S Pace
Journal:  J Biol Chem       Date:  2010-11-13       Impact factor: 5.157

3.  Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta.

Authors:  Farah H Bardai; Santosh R D'Mello
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

Review 4.  Regulation of Central Nervous System Development by Class I Histone Deacetylases.

Authors:  Santosh R D'Mello
Journal:  Dev Neurosci       Date:  2020-01-24       Impact factor: 2.984

5.  Expression of Class I Histone Deacetylases in Ipsilateral and Contralateral Hemispheres after the Focal Photothrombotic Infarction in the Mouse Brain.

Authors:  Svetlana Demyanenko; Maria Neginskaya; Elena Berezhnaya
Journal:  Transl Stroke Res       Date:  2017-12-07       Impact factor: 6.829

6.  HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.

Authors:  Corrado Caslini; Sunhwa Hong; Yuguang J Ban; Xi S Chen; Tan A Ince
Journal:  Oncogene       Date:  2019-08-02       Impact factor: 9.867

Review 7.  Class IIA HDACs in the regulation of neurodegeneration.

Authors:  Nazanin Majdzadeh; Brad E Morrison; Santosh R D'Mello
Journal:  Front Biosci       Date:  2008-01-01

8.  Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea.

Authors:  Fu-Quan Chen; Jochen Schacht; Su-Hua Sha
Journal:  J Neurochem       Date:  2009-01-29       Impact factor: 5.372

Review 9.  The Role of PI3K/Akt and ERK in Neurodegenerative Disorders.

Authors:  Sachchida Nand Rai; Hagera Dilnashin; Hareram Birla; Saumitra Sen Singh; Walia Zahra; Aaina Singh Rathore; Brijesh Kumar Singh; Surya Pratap Singh
Journal:  Neurotox Res       Date:  2019-02-01       Impact factor: 3.911

10.  KSRP: a checkpoint for inflammatory cytokine production in astrocytes.

Authors:  Xuelin Li; Wei-Jye Lin; Ching-Yi Chen; Ying Si; Xiaowen Zhang; Liang Lu; Esther Suswam; Lei Zheng; Peter H King
Journal:  Glia       Date:  2012-07-28       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.